The National Ataxia Foundation, based in Minneapolis, will host its 66th Annual Ataxia Conference at Planet Hollywood in Las Vegas, Nevada on March 30 – April 1, 2023. Attendees will have the opportunity to learn from world-leading Ataxia clinicians and researchers, network with other families affected by Ataxia, and enjoy social events.
The National Ataxia Foundation, a leading nonprofit organization established to help persons with Ataxia and their families, supports the NFL and NFLPA’s addition of “ataxia” to the NFL’s concussion protocol. Ataxia describes an impairment of coordinated movement resulting from brain or nerve dysfunction. Many symptoms of ataxia mimic the physical effects of excessive drinking, such as slurred speech, imbalance, stumbling, and difficulty with fine motor skills.
The National Ataxia Foundation today announced that the Centre hospitalier de l’Université de Montréal (CHUM) will be the first international clinical site to join the Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA).
The National Ataxia Foundation, a leading nonprofit organization established to help persons with Ataxia and their families, today announced plans to partner with SCAsource, an Ataxia research news website. SCAsource offers peer-reviewed articles about research on Ataxias, written in plain language. The strategic partnership will eliminate SCAsource’s administrative costs and offer easy-to-read, scientific articles to NAF’s members.
The National Ataxia Foundation (NAF) announced the hiring of the organization’s first Chief Scientific Officer, Lauren Moore, PhD, following an extensive nationwide search. She will lead NAF’s Ataxia research grant program as well as continue to expand relationships with the growing number of biotech and pharmaceutical companies who are working on developing treatments for Ataxia.
The National Ataxia Foundation (NAF), the Friedreich’s
Ataxia Research Alliance (FARA), and Ataxia UK are pleased to announce the date
for the inaugural International Congress for Ataxia Research (ICAR) to be held at the
Caribe Royale resort in Orlando, Florida, USA on March 15th – 18th, 2022.
The National Ataxia Foundation (NAF) announced today the launch of the NAF Drug Development Collaborative. This pre-competitive pharmaceutical industry consortium has a principal goal of accelerating the development of treatments for Ataxia. The group will address the many shared opportunities and challenges in therapy development for this complex neurological disease.
The National Ataxia Foundation (NAF) Board of Directors and staff announced their new Executive Director, Andrew Rosen, following a nationwide search conducted by a committee of the Board of Directors. He will lead NAF’s efforts in improving the lives of persons affected by Ataxia through support, education, and research.
Non-profit based in Minneapolis will accept resumes from qualified candidates until the position is filled, with submissions to be considered in the first screening due by December 21, 2018.
National Ataxia Foundation celebrates International Ataxia Awareness Day (IAAD) with various outreach strategies to bring awareness to this rare disease.
Weeks after the dreaded accident happened, the NFL and NFLPA found out that “the outcome in this case is not what was intended when the Protocols were drafted.” The mentioned concussion protocols will keep the players from playing if they are experiencing ataxia. The condition, according to the National Ataxia Foundation, is a rare neurological disease that affects a person’s mobility due to damage to the cerebellum. Poor muscle control leads to a lack of coordination, as well.
The community is invited to attend the Whitinsville Scramble to Cure Ataxia. The event will be held Oct. 24 at the Whitinsville Country Club.
The first annual National Ataxia Foundation Bowl for a Cure is taking place this Sunday. We were joined Thursday, Sept. 22 by several special guests to discuss the importance of the fundraiser, as well as why it is so important to battle ataxia.
Karsen Stephens is a student of the Diesel Program at High Plains Technology Center and also suffers from Ataxia which is a rare neurological disease. Students donated some funds to the cause and began fundraising. Word spread and several local businesses and individuals wanted to contribute. A total of $15,000 was raised for the customized track chair for Stephens.
New preclinical research by Dr. Laura Ranum, a member of NAF’s Medical Research Advisory Board, shows a commonly used Type 2 diabetes drug can improve symptoms in a specific genetic form of ALS and frontotemporal dementia in mice.
Ataxia is a neurological disease that causes balance and motor coordination problems and other symptoms, according to the NAF. There is no cure for Ataxia but the Walk n’ Roll raises money to help research a cure and support those living with the disease.
“The walk is a walk, obviously, but the roll is because the majority of people who are participating and have ataxia are using either walkers, canes, wheelchairs or scooters. The idea is their caregivers or family members will be walking, and they’ll be rolling.”
Using biochemical and structural studies, they found that in AOA1, aprataxin mutations affect protein stability, how repair proteins bind to DNA, and the rate of the chemical reaction, which is known as catalysis. The team also uncovered a dominant mutation that affects the enzymatic reaction that normally reverses DNA damage.
The National Ataxia Foundation (NAF) is a non-profit organization dedicated to finding a cure for Ataxia. Read our press kit to learn more information about us.
The NFL and the NFL Players Association added "ataxia" to the concussion protocol for players who have experienced head injuries during play. This press kit offers information about concussion-related ataxia.
Donation match provided by Priority Courier Experts and the Cossack Foundation
Every $1 you donate to the 2022 Research Drive will be matched with a $2 donation!